You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HPV-16 E6/E7

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head and Neck Squamous Cell Carcinoma, Melanoma, Cervical Cancer Trial in United States (RPTR-168)

Terminated
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
  • RPTR-168
  • Scottsdale, Arizona
  • +3 more
Dec 2, 2022

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus-Related Carcinoma, Locally

Recruiting
  • Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +5 more
  • Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101
  • Pembrolizumab
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Oropharyngeal Cancer, Human Papilloma Virus, Head Neck Cancer Trial (Fludarabine, Cyclophosphamide, NEXI-003 T cells)

Not yet recruiting
  • Oropharyngeal Cancer
  • +10 more
  • (no location specified)
Dec 14, 2022

HPV Infection, HPV-Related Cervical Carcinoma Trial (FluBHPVE6E7, Placebo)

Not yet recruiting
  • HPV Infection
  • HPV-Related Cervical Carcinoma
  • FluBHPVE6E7
  • Placebo
  • (no location specified)
Apr 24, 2023

Solid Tumor Trial in Wuhan (HPV-T, Interleukin-2)

Recruiting
  • Solid Tumor
  • Wuhan, Hubei, China
    Wuhan Union Hospital
May 31, 2023

Human Papillomavirus-Related Carcinoma, Human Papillomavirus Positive Oropharyngeal Carcinoma, Human Papillomavirus Positive

Active, not recruiting
  • Human Papillomavirus-Related Carcinoma
  • +5 more
  • HPV Specific T Cells
  • +3 more
  • Houston, Texas
    Houston Methodist Hospital
Jan 10, 2022

Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified, Stage IB3 Cervical Cancer FIGO 2018, Stage II

Recruiting
  • Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified
  • +13 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 31, 2022

HPV Infection Trial in Vienna (FluBHPVE6E7)

Recruiting
  • HPV Infection
  • FluBHPVE6E7
  • Vienna, Austria
    Medical University of Vienna
Sep 23, 2021

Human Papillomavirus Type 16, Cervical Intraepithelial Neoplasia Grade II, Cervical Intraepithelial Neoplasia, Grade III Trial

Recruiting
  • Human Papillomavirus Type 16
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins University
Jul 2, 2021

Cervical Carcinoma Trial in Chongqing (TC-E202 cells, IL-2, Fludarabine)

Recruiting
  • Cervical Carcinoma
  • TC-E202 cells
  • +3 more
  • Chongqing, Chongqing, China
    Xiaochun Cheng
Oct 20, 2022

HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma, HPV-Related Malignancy Trial in New Brunswick (Conditioning, E7 TCR-T

Not yet recruiting
  • HPV-Associated Cervical Carcinoma
  • +16 more
  • Conditioning, E7 TCR-T cells, and aldesleukin
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jan 17, 2023

Cervical Cancer, Throat Cancer, Oropharynx Cancer Trial in New Brunswick (E7 TCR-T cells)

Not yet recruiting
  • Cervical Cancer
  • +20 more
  • E7 TCR-T cells
  • New Brunswick, New Jersey
  • +1 more
Jan 18, 2023

HPV-Related Carcinoma Trial (IBRX-042)

Not yet recruiting
  • HPV-Related Carcinoma
  • (no location specified)
Jul 26, 2023

Head and Neck Squamous Cell Carcinoma Trial in Seoul (GX-188E+GX-I7+Pembrolizumab)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
May 18, 2022

Head and Neck Squamous Cell Carcinoma Trial in Seoul (nivolumab-GX-188E-GX-I7)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Apr 20, 2022

Cancer of Head and Neck, Cancer of Cervix, Cancer of Anus Trial in Boston (DPX-E7 vaccine)

Active, not recruiting
  • Cancer of Head and Neck
  • +2 more
  • DPX-E7 vaccine
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Feb 18, 2022

HPV-associated Oropharyngeal Cancer

Recruiting
  • PREDICTIVE BIOMARKERS
  • +2 more
  • HPV-ASSOCIATED OROPHARYNGEAL CANCER
  • Rome, Italy
    "Regina Elena" National Cancer Institute
Oct 19, 2023

Head Neck Cancer Trial in Little Rock (PepCan, Placebo)

Recruiting
  • Head and Neck Cancer
  • PepCan
  • Placebo
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Oct 18, 2022

HPV-Associated Cancers Trial in Canada, United States (Ad-E6E7, MG1-E6E7, Atezolizumab)

Active, not recruiting
  • HPV-Associated Cancers
  • Ad-E6E7
  • +2 more
  • Miami, Florida
  • +7 more
Sep 30, 2021

Papillomavirus Infections, Oropharyngeal Tumors Trial run by the NCI (E7 T-Cell Receptor (TCR))

Terminated
Has Results
  • Papillomavirus Infections
  • Oropharyngeal Neoplasms
  • E7 T-Cell Receptor (TCR)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 3, 2022

Cervical Intraepithelial Neoplasia Trial in Little Rock (PepCan, Candin®)

Active, not recruiting
  • Cervical Intraepithelial Neoplasia
  • PepCan
  • Candin®
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
May 17, 2022

Unresectable Head and Neck Squamous Cell Carcinoma, Metastatic Head Neck Cancer, Recurrent Head Neck Cancer Trial in Worldwide

Recruiting
  • Unresectable Head and Neck Squamous Cell Carcinoma
  • +2 more
  • BNT113
  • Pembrolizumab
  • Los Angeles, California
  • +79 more
Jan 9, 2023

Cervical Intraepithelial Neoplasia, Cervical Cancer, Condylomata Acuminata Trial in Nanjing, Chengdu (Nonavalent HPV vaccine,

Active, not recruiting
  • Cervical Intraepithelial Neoplasia
  • +2 more
  • Nonavalent HPV vaccine
  • Bivalent HPV vaccine
  • Nanjing, Jiangsu, China
  • +1 more
Feb 10, 2022

Tumors or Premalignant Lesions Trial in Leiden (Hespecta)

Completed
  • Tumors or Premalignant Lesions
  • Hespecta
  • Leiden, Netherlands
    Leiden University Medical Center
Feb 17, 2021

Oropharyngeal Cancer Trial in Canada (Radiation, Cisplatin)

Active, not recruiting
  • Oropharyngeal Cancer
  • Prince George, British Columbia, Canada
  • +13 more
Dec 12, 2022